Source - SMW
Numis today upgrades its investment rating on Hikma Pharmaceuticals PLC (LON:HIK) to buy (from add) and set its price target at 1300p.

Related Charts

Hikma Pharmaceuticals (HIK)

+20.00p (+1.96%)
delayed 17:08PM